Thomas J. Valente, MD

Dr Valente is a psychiatrist in Leesburg, Florida.

Articles by Thomas J. Valente, MD

Interdisciplinary Consensus Guidelines on Stuttering (Childhood-Onset Fluency Disorder): Addressing Issues in Diagnosis, Treatment, and Unmet Needs

ByGerald A. Maguire, MD,Heidi Anne Duerr, MPH,Shahriar SheikhBahaei, PhD,Yoshikazu Kikuchi, MD, PhD,Lisa LaSalle PhD, CCC-SLP,Thomas J. Valente, MD,Anelise Junqueira Bohne, PhD, SLP,Tiago Proença dos Santos, MD,Gonçalo Leal, SLP,Devin Binder, MD, PhD,Gustavo Alva, MD, DFAPA,Greg Mattingly, MD

August 10th 2026

STARS experts redefine stuttering as a brain-based neuropsychiatric disorder, urging interdisciplinary care and warning dopamine-boosting ADHD or antidepressant meds may worsen symptoms.

Inspiring Women: Psychiatrists Share Who Influenced Their Careers for Women's History Month

ByFreda Lewis-Hall, MD,Thomas J. Valente, MD,Gustavo Alva, MD, DFAPA

March 31st 2026

Psychiatrists share women who inspire them for Women's History Month.

Psychiatry’s Role in Stuttering: Experts Call for Treatment Guidelines and Better Clinical Support

ByThomas J. Valente, MD

March 5th 2026

Thomas J. Valente, MD, explains the need for evidence-based guidelines for stuttering and says psychiatrists can help lead care, reduce stigma, and improve support for patients.

Thomas J. Valente, MD

Articles by Thomas J. Valente, MD

Interdisciplinary Consensus Guidelines on Stuttering (Childhood-Onset Fluency Disorder): Addressing Issues in Diagnosis, Treatment, and Unmet Needs

Inspiring Women: Psychiatrists Share Who Influenced Their Careers for Women's History Month

Psychiatry’s Role in Stuttering: Experts Call for Treatment Guidelines and Better Clinical Support

Latest Updated Articles

Trending on Psychiatric Times

Kratom Component in Clinical Trial for Opioid Use Disorder

NIDA Awards PleoPharma $6.5 Million Grant to Advance Phase 3 Trial of PP-01 for Cannabis Use Disorder

Why Cultural Context Matters in Psychiatric Assessment

FDA Feedback Paves Way for New IND Filing for PT00114 in Generalized Anxiety Disorder

Brain Function Biomarker Testing In Psychiatry With Universal Brain EEG